Latest Manufacturing News

Alpha HPA Limited has announced key leadership changes, appointing Rob Williamson as Managing Director and repositioning Rimas Kairaitis as Executive Director and Chief Commercial Officer to support its next growth phase.

Top Shelf International Holdings reports a $2 million underlying EBITDA loss in Q2 FY25, while pursuing the sale of its Campbellfield facility and exploring capital raising options amid ongoing trading suspension.

PARKD Ltd has secured a 7-day extension to its exclusive licence agreement with Fielders Steel Roofing, following successful proof-of-concept projects for its Metal Deck Support System. The extension aims to finalise terms for a longer-term commercial partnership.

NGX Limited has developed an innovative process that converts previously discarded graphite fines into high-value spherical graphite, significantly enhancing production yields and the economic potential of its Malingunde Graphite Project.

ResMed Inc. reported robust financial results for the quarter ended December 31, 2024, with a 10% increase in net revenue and a 65% jump in net income, driven by strong demand across its Sleep and Breathing Health and Residential Care Software segments.

Fisher & Paykel Healthcare anticipates increased costs from newly imposed US tariffs on imports from Mexico and China, potentially delaying its gross margin recovery timeline but expects no immediate profit impact for FY2025.

Lithium Energy Limited has secured unconditional shareholder approval for the amended sale of its Solaroz Lithium Brine Project, with completion now staged over two tranches through January 2026. Meanwhile, the company prepares for the Axon Graphite spin-out IPO, navigating an ongoing ASX trading suspension due to operational thresholds.

Rewardle Holdings Limited reported a robust net cash inflow from operating activities of $3.98 million for Q4 2024, offsetting significant investing outflows and ending the quarter with $1.23 million in cash.

Yowie Group’s Q2 FY25 results reveal a mixed performance with a 33% revenue drop in North America offset by growth in Australia and ongoing cost optimisation efforts.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.

Skin Elements Limited reports steady progress in commercialising its plant-based SE Formula biotechnology, highlighted by ongoing product trials, a successful R&D rebate, and a $513k non-renounceable entitlement issue.

K-TIG Limited reports steady cash receipts and operational efficiencies while progressing a strategic acquisition and a significant capital raise to fuel growth.